Direktorat Registrasi ObatValid

RIVAROXABAN

Claim this product
BPOM Number
GKL2657902317B1
Approved
24 August 2026
Expiry
23 August 2031
Form
TABLET SALUT SELAPUT

About This Registration

RIVAROXABAN is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL2657902317B1. Its current registration status is Valid, with the licence valid until 23 August 2031. The product is registered to ETANA BIOTECHNOLOGIES INDONESIA - INDONESIA. BPOM first approved this registration in August 2026. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 25 August 2026. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application
newaero
Packaging
DUS, 3 BLISTER @10 TABLET SALUT SELAPUT
Department
Direktorat Registrasi Obat
Data Last Updated
25 August 2026

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

  • ETANA BIOTECHNOLOGIES INDONESIA - INDONESIA

    KODYA JAKARTA TIMUR

    NPWP: 12345678910

    owner
    View profile →

Manufacturing Sites

Ingredients (1)

RIVAROXABAN

Market Intelligence

Owner Portfolio
ETANA BIOTECHNOLOGIES INDONESIA - INDONESIA holds 68 BPOM registrations
Manufacturer Scale
ETANA BIOTECHNOLOGIES INDONESIA - INDONESIA produces 68 registered products
Update Status
Recently updated (8 days ago)

FDA Cross-Reference

via openFDA
Generic Name
RIVAROXABAN
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
ORAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product
1